Clinical Pharmacology and Drug Toxicity Practice Questions

Q: What is the antidote for copper poisoning?

Potassium ferrocyanide. **Explanation:** The correct answer is **Potassium ferrocyanide**. In cases of acute copper poisoning (often due to ingestion of copper sulfate/blue vitriol), **Potassium ferrocyanide** is considered the specific chemical antidote. When administered, it reacts with copper sulfate in the stomach to form **cupric ferrocyanide**, which is an insoluble, non-toxic precipitate. This prevents the systemic absorption of copper, effectively neutralizing the poison locally. **Analysis of Options:** * **A. D-penicillamine:** While this is the drug of choice for **chronic copper toxicity** (Wilson’s Disease) and can be used as a systemic chelator in acute poisoning after stabilization, it is not the specific neutralizing agent for acute ingestion in the gastrointestinal tract. * **C. BAL (British Anti-Lewisite/Dimercaprol):** This is a chelating agent primarily used for heavy metals like **Arsenic, Mercury, and Lead**. It is generally avoided in copper poisoning unless other options are unavailable. * **D. Desferrioxamine:** This is the specific chelating agent for **Iron toxicity**. **High-Yield Clinical Pearls for NEET-PG:** * **Acute Copper Poisoning:** Characterized by a metallic taste, blue-green vomitus (due to copper sulfate), and "Green Hair" in chronic exposure. * **Wilson’s Disease:** A genetic disorder of copper metabolism where **D-penicillamine** or **Trientine** are used for long-term management. * **Zinc:** Oral zinc is used in Wilson’s disease to block intestinal absorption of copper by inducing metallothionein. * **Universal Antidote:** Consists of Charcoal, Magnesium oxide, and Tannic acid (though largely replaced by Activated Charcoal).

Q: Which of the following is the most appropriate therapy for an individual who has ingested an overdose of aspirin?

Sodium Bicarbonate. The correct answer is **Sodium Bicarbonate**. Aspirin (acetylsalicylic acid) is a weak acid [2]. In cases of salicylate toxicity, the primary goal of management is to enhance elimination and prevent the drug from crossing the blood-brain barrier [1]. **Why Sodium Bicarbonate is the treatment of choice:** 1. **Urinary Alkalinization:** By administering IV Sodium Bicarbonate, the urine pH is increased. In an alkaline environment, salicylic acid dissociates into its ionized (charged) form. Ionized molecules are lipid-insoluble and cannot be reabsorbed by the renal tubules, leading to "ion trapping" and increased excretion [2]. 2. **Serum Alkalinization:** Increasing blood pH shifts the equilibrium of salicylate out of the central nervous system and into the extracellular compartment, reducing neurotoxicity. **Analysis of Incorrect Options:** * **A. Acetazolamide:** Although it alkalinizes the urine, it causes **metabolic acidosis** in the blood [1]. This promotes the movement of salicylic acid into the brain, worsening toxicity and increasing mortality. * **C. Flumazenil:** This is a competitive benzodiazepine receptor antagonist used for benzodiazepine overdose, not salicylate poisoning. * **D. Allopurinol:** This is a xanthine oxidase inhibitor used for chronic gout management and tumor lysis syndrome; it has no role in acute aspirin overdose. **High-Yield NEET-PG Pearls:** * **Classic Triad of Salicylate Poisoning:** Tinnitus, hyperventilation (respiratory alkalosis), and metabolic acidosis (anion gap) [1]. * **Mixed Acid-Base Disorder:** The most common presentation is a mixed respiratory alkalosis and metabolic acidosis. * **Indications for Hemodialysis:** Salicylate level >100 mg/dL (acute) or >60 mg/dL (chronic), refractory acidosis, or altered mental status.

Q: Which of the following is not typically monitored in a patient receiving Methotrexate therapy?

Eye examination. **Explanation:** Methotrexate (MTX) is a folate antagonist that inhibits dihydrofolate reductase (DHFR), leading to interference with DNA synthesis. While it is a cornerstone in treating malignancies and autoimmune conditions (like Rheumatoid Arthritis), it carries a significant profile of multisystem toxicities that necessitate stringent monitoring. **Why Eye Examination is the Correct Answer:** Unlike drugs such as Hydroxychloroquine (which requires baseline and periodic fundoscopy for retinopathy) or Ethambutol (optic neuritis), **Methotrexate is not associated with significant ocular toxicity.** Therefore, routine eye examinations are not a standard part of the MTX monitoring protocol. **Why the other options are monitored:** * **Hemogram (D):** MTX causes **bone marrow suppression** (myelosuppression), leading to leucopenia, thrombocytopenia, and macrocytic anemia. Frequent CBC counts are mandatory. * **Liver Function Tests (A):** Chronic use can lead to **hepatotoxicity**, ranging from elevated transaminases to hepatic fibrosis and cirrhosis. Baseline and periodic LFTs are essential. * **Lung Function Tests (B):** MTX can cause idiosyncratic **interstitial pneumonitis** or pulmonary fibrosis. Baseline chest X-rays and monitoring for respiratory symptoms (dry cough, dyspnea) are required. **High-Yield Clinical Pearls for NEET-PG:** * **Rescue Therapy:** **Leucovorin (Folinic acid)** is used to "rescue" normal cells from MTX toxicity by bypassing the inhibited DHFR enzyme. * **Excretion:** MTX is primarily excreted by the kidneys; thus, renal function (Creatinine) must also be monitored to prevent toxic accumulation. * **Contraindication:** It is highly **teratogenic** (Neural tube defects) and contraindicated in pregnancy. * **Acute Toxicity:** High doses can cause **mucositis** and crystals in the urine (crystalluria).

Q: Forced alkaline diuresis is effective in the management of poisoning by which of the following agents?

Phenobarbitone. **Explanation:** The correct answer is **Phenobarbitone**. **Mechanism of Forced Alkaline Diuresis (FAD):** The principle behind FAD is **ion trapping**. Phenobarbitone is a **weakly acidic drug**. By administering intravenous sodium bicarbonate, the urine is alkalinized (pH > 7.5). In an alkaline medium, acidic drugs become ionized (polar). Since ionized molecules cannot easily cross the lipid membrane of the renal tubules, their reabsorption back into the bloodstream is prevented, thereby "trapping" them in the urine and enhancing their excretion. FAD is also effective for **Salicylates (Aspirin)**. **Analysis of Incorrect Options:** * **B. Lead:** Heavy metal poisoning is managed with **chelating agents** like Calcium disodium EDTA, Succimer (DMSA), or Penicillamine. * **C. Iron:** Acute iron toxicity is treated with the specific chelator **Deferoxamine**. FAD has no role as iron does not exist as a simple weak acid in the blood. * **D. Organophosphates:** These inhibit acetylcholinesterase. Management involves **Atropine** (muscarinic antagonist) and **Pralidoxime** (enzyme reactivator). **High-Yield Clinical Pearls for NEET-PG:** 1. **Forced Acidic Diuresis:** Historically used for weak bases (e.g., Amphetamines, Quinine), it is **no longer recommended** due to the risk of precipitating acute renal failure from myoglobinuria. 2. **Prerequisites for FAD:** The drug must be primarily excreted by the kidneys and have a low volume of distribution ($V_d$). 3. **Complications:** Monitor for hypokalemia, pulmonary edema, and metabolic alkalosis during FAD. 4. **Specific Antidote:** For Phenobarbitone, there is no specific pharmacological antagonist; management is supportive plus FAD or Hemodialysis in severe cases.

Q: Which one of the following drugs is the most common cause of progressive multifocal leukoencephalopathy?

Natalizumab. **Explanation:** **Progressive Multifocal Leukoencephalopathy (PML)** is a rare, often fatal demyelinating disease of the CNS caused by the reactivation of the **JC virus** (John Cunningham virus). This occurs almost exclusively in immunocompromised individuals or those on specific immunomodulatory therapies. **Why Natalizumab is the correct answer:** Natalizumab is a monoclonal antibody against **$\alpha$4-integrin**. By blocking this integrin, it prevents leukocytes from crossing the blood-brain barrier (BBB) to enter the CNS. While this is effective in treating **Multiple Sclerosis (MS)** and Crohn’s disease by reducing inflammation, it creates a state of "localized immune surveillance deficiency" in the brain. This allows the latent JC virus to replicate unchecked, making Natalizumab the drug most strongly and commonly associated with PML. **Analysis of Incorrect Options:** * **Rituximab (Anti-CD20):** While Rituximab is the second most common monoclonal antibody associated with PML (often in patients with hematological malignancies or SLE), the statistical risk and direct association are significantly higher with Natalizumab. * **Cetuximab (Anti-EGFR):** Used in colorectal and head/neck cancers; it is not typically associated with PML. * **Bevacizumab (Anti-VEGF):** An angiogenesis inhibitor used in various cancers; it does not significantly impair T-cell surveillance in the CNS and is not a cause of PML. **High-Yield Clinical Pearls for NEET-PG:** * **Black Box Warning:** Natalizumab has a boxed warning for PML. * **Risk Stratification:** The risk of PML increases with the duration of treatment (especially >2 years), prior use of immunosuppressants, and positive **anti-JCV antibody status**. * **Clinical Presentation:** Patients present with subacute neurological deficits (altered mental status, visual loss, or motor weakness) and MRI showing multifocal white matter lesions without mass effect.

Q: Quinine-induced thrombocytopenia is:

Antibody-mediated. ### Explanation **Correct Answer: A. Antibody-mediated** Quinine-induced thrombocytopenia (QITP) is a classic example of **drug-induced immune thrombocytopenia (DITP)**. The mechanism involves the formation of **drug-dependent antibodies** (usually IgG or IgM). These antibodies bind to specific glycoproteins on the platelet surface (most commonly **GPIb/IX** or **GPIIb/IIIa**) only in the presence of the drug. This binding leads to platelet destruction by the reticuloendothelial system, causing a rapid and severe drop in platelet counts. **Why other options are incorrect:** * **B. Dose-related toxicity:** QITP is not related to the plasma concentration of the drug. Even minute amounts (e.g., "tonic water" ingestion) can trigger a massive immune response in sensitized individuals. * **C. Idiosyncratic reaction:** While the reaction is unpredictable, "Antibody-mediated" is a more specific and accurate description of the underlying pathophysiology. In pharmacology exams, always choose the specific mechanism over a general term. * **D. Inhibits production of platelets:** Quinine causes peripheral destruction of mature platelets rather than suppressing their production in the bone marrow (unlike drugs like linezolid or chemotherapy). **High-Yield Clinical Pearls for NEET-PG:** * **Cinchonism:** The most common side effect of Quinine, characterized by tinnitus, high-frequency hearing loss, dizziness, and blurred vision. * **Blackwater Fever:** A severe complication of Quinine/Malaria causing massive intravascular hemolysis and hemoglobinuria. * **Hypoglycemia:** Quinine stimulates pancreatic beta cells to release insulin; monitor blood glucose during IV administration. * **QT Prolongation:** Quinine has class 1A antiarrhythmic-like properties and can cause Torsades de Pointes.

Q: Which of the following can cause acute tubular necrosis?

Both of the above. **Explanation:**Acute Tubular Necrosis (ATN) is a common cause of intrinsic acute kidney injury (AKI) characterized by damage to the renal tubular epithelial cells. It can be caused by ischemia or, as in this case, **nephrotoxins**.**1. Radiocontrast Agents (Option A):** Contrast-induced nephropathy is a leading cause of hospital-acquired ATN. These agents cause renal injury through two mechanisms: **direct cytotoxicity** to the tubular cells and **intense renal vasoconstriction** leading to medullary ischemia. The damage typically manifests as a rapid but often reversible decline in GFR.**2. Amphotericin B (Option B):** This "nephrotoxic" antifungal causes ATN [1] by binding to ergosterol in the cell membrane, which creates pores that increase membrane permeability. This leads to **direct tubular toxicity** (especially in the distal tubule) and **afferent arteriolar vasoconstriction**, reducing renal blood flow. It is classically associated with distal Renal Tubular Acidosis (Type 1 RTA) and significant electrolyte wasting (hypokalemia and hypomagnesemia).Since both agents are well-documented causes of drug-induced ATN, **Option C** is the correct answer.**High-Yield Clinical Pearls for NEET-PG:** * **Other common causes of ATN:** Aminoglycosides (Gentamicin), Cisplatin, NSAIDs, and Myoglobin (Rhabdomyolysis).* **Urinary Findings:** ATN is characterized by the presence of **"Muddy brown" granular casts** in the urine sediment.* **Prevention:** The most effective strategy to prevent contrast-induced ATN is **adequate hydration** (Isotonic saline) before the procedure. For Amphotericin B, using **liposomal formulations** significantly reduces nephrotoxicity [1].* **Fractional Excretion of Sodium (FeNa):** In ATN, FeNa is typically **>2%**, indicating the tubules' inability to reabsorb sodium.

Q: Benzodiazepine overdose in a patient presenting with coma is treated by:

Flumazenil. **Explanation:** **Correct Answer: B. Flumazenil** Benzodiazepines (BZDs) act by enhancing the effect of the inhibitory neurotransmitter GABA at the **GABA-A receptor**. They bind to a specific site on the receptor complex, increasing the frequency of chloride channel opening. **Flumazenil** is a competitive antagonist at the benzodiazepine binding site. It rapidly reverses the sedative, psychomotor, and respiratory-depressant effects of BZDs, making it the specific antidote for overdose. **Analysis of Incorrect Options:** * **A. Protamine:** This is the specific antidote for **Heparin** overdose. It is a highly basic protein that neutralizes the acidic heparin molecule. * **C. Coumarin:** This is a class of anticoagulants (e.g., Warfarin). It is not an antidote; rather, its toxicity is treated with Vitamin K or Fresh Frozen Plasma (FFP). * **D. Midazolam:** This is a short-acting benzodiazepine itself. Administering it would worsen the coma and respiratory depression in an overdose scenario. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Flumazenil is a competitive antagonist; it does *not* reverse the effects of Barbiturates or Alcohol (which act on different sites of the GABA receptor). * **Risk of Seizures:** Use Flumazenil with caution in patients with long-term BZD dependence or those who have co-ingested tricyclic antidepressants (TCAs), as it can precipitate **acute withdrawal seizures**. * **Half-life:** Flumazenil has a very short half-life (~1 hour). Since most BZDs have a longer duration of action, "re-sedation" can occur, requiring repeated doses or an infusion. * **Z-drugs:** Flumazenil also reverses the effects of non-benzodiazepine hypnotics like Zolpidem, Zaleplon, and Eszopiclone.

Question 1

What is the antidote for copper poisoning?

Accepted Answer

Potassium ferrocyanide

Answer

D-penicillamine

Answer

BAL

Answer

Desferrioxamine

Question 2

What is a known complication of cyclosporine therapy?

Accepted Answer

Hypertension

Answer

Pulmonary fibrosis

Answer

Corneal deposits

Answer

Nephrotoxicity

Question 3

Which of the following is the most appropriate therapy for an individual who has ingested an overdose of aspirin?

Accepted Answer

Sodium Bicarbonate

Answer

Acetazolamide

Answer

Flumazenil

Answer

Allopurinol

Question 4

Which of the following is not typically monitored in a patient receiving Methotrexate therapy?

Accepted Answer

Eye examination

Answer

Liver function tests

Answer

Lung function tests

Answer

Hemogram

Question 5

Forced alkaline diuresis is effective in the management of poisoning by which of the following agents?

Accepted Answer

Phenobarbitone

Answer

Lead

Answer

Iron

Answer

Organophosphates

Question 6

Which one of the following drugs is the most common cause of progressive multifocal leukoencephalopathy?

Accepted Answer

Natalizumab

Answer

Cetuximab

Answer

Rituximab

Answer

Bevacizumab

Question 7

Quinine-induced thrombocytopenia is:

Accepted Answer

Antibody-mediated

Answer

Dose-related toxicity

Answer

Idiosyncratic reaction

Answer

Inhibits production of platelets

Question 8

Which of the following statements regarding the management of iron toxicity in a 3-year-old child presenting with severe GI distress, hematemesis, a shock-like state with marked dehydration, and progressive hemorrhagic gastritis is accurate?

Accepted Answer

Deferoxamine should be administered as soon as possible.

Answer

Gastric lavage should not be attempted due to the risk of aspiration.

Answer

The patient is likely to have a reduced anion gap.

Answer

Urinary alkalization increases the elimination of iron.

Question 9

Which of the following can cause acute tubular necrosis?

Accepted Answer

Both of the above

Answer

Radiocontrast agents

Answer

Amphotericin B

Answer

None of the above

Question 10

Benzodiazepine overdose in a patient presenting with coma is treated by:

Accepted Answer

Flumazenil

Answer

Protamine

Answer

Coumarin

Answer

Midazolam

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?